Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Platelet Rich Plasma Eye Drops for Treatment of Ocular Surface Disease

NCT04608084 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT04608084
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04608084 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Platelet Rich Plasma Eye Drops for Treatment of Ocular Surface Disease
Lead sponsor
University Health Network, Toronto
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2021
Completion date
January 31, 2023
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye syndromes, ocular surface disease